Kolkata-based Suraksha Diagnostic Ltd, known for its comprehensive diagnostic services, is set to launch its Initial Public Offering (IPO) on November 29, 2024. The IPO, with a price band of Rs 42-441 per share, will have a pure Offer-for-Sale of 19,189,330 equity shares worth Rs 846.25 crore. Promoters of the company, including Somnath Chatterjee, Ritu Mittal, and Satish Kumar Verma, will be selling their stake in the IPO.
Suraksha Diagnostics IPO: A Deep Dive into the Healthcare Giant
Introduction
Suraksha Diagnostics Private Limited, a renowned healthcare provider based in Kolkata, is gearing up for its Initial Public Offering (IPO) on November 29, 2024. This major development marks a significant milestone in the company's journey, and investors eagerly await the opportunity to participate.
Company Overview
Established in 1988, Suraksha Diagnostics has become a leading player in the diagnostic sector, offering a comprehensive range of services including pathology, radiology, and genetics. With a network of over 100 diagnostic centers across India, the company has a strong national presence and a loyal customer base.
IPO Details
The Suraksha Diagnostics IPO will comprise a pure Offer-for-Sale (OFS) of 19,189,330 equity shares, with a price band of Rs 42-441 per share. The OFS will result in the dilution of 26.2% of the company's post-issue share capital.
The proceeds from the IPO will be used to fund the company's expansion plans, including the establishment of new diagnostic centers and the acquisition of advanced equipment.
Promoters and Management
Suraksha Diagnostics is promoted by a team of experienced healthcare professionals, including Somnath Chatterjee, Ritu Mittal, and Satish Kumar Verma. The company's management team boasts a deep understanding of the industry and a commitment to delivering high-quality healthcare services.
Financial Performance
Suraksha Diagnostics has consistently delivered strong financial performance, with increasing revenue and profits over the past several years. The company's financials are robust, indicating its ability to withstand market fluctuations.
Top 5 FAQs
1. When will the Suraksha Diagnostics IPO open and close? The IPO will open on November 29, 2024, and close on December 1, 2024.
2. What is the price band for the IPO? The price band for the IPO is Rs 42-441 per share.
3. How many shares will be offered in the IPO? A total of 19,189,330 equity shares will be offered in the IPO.
4. What is the purpose of the IPO proceeds? The proceeds from the IPO will be used to fund the company's expansion plans and acquire new equipment.
5. Who are the promoters of Suraksha Diagnostics? The promoters of Suraksha Diagnostics are Somnath Chatterjee, Ritu Mittal, and Satish Kumar Verma.
Conclusion
The Suraksha Diagnostics IPO is a significant opportunity for investors to gain exposure to a rapidly growing healthcare provider. With its strong financial performance, experienced management team, and commitment to delivering quality healthcare, Suraksha Diagnostics is well-positioned for future success. As the IPO date approaches, investors should carefully consider the company's fundamentals before making investment decisions.
The Indian government has stepped in to support its exporters amidst high tariffs imposed by the US. This includes providing assistance and facilitating access to domestic buyers for exporters. However, India may face challenges in the coming months with additional tariffs on Russian oil, impacting its export growth to the US.
After nearly four days of striking and thousands of passengers being stranded, the Canadian Union of Public Employees (CUPE) and Air Canada have reached a tentative agreement, bringing a halt to the strike. The airline plans to gradually resume flights starting Tuesday evening, but warns that it could take up to a week before operations return to normal. The deal, still to be ratified by union members, addresses key issues such as pay and hours, and is described as bringing "transformational change" for workers and the industry. Passengers are advised to only head to the airport if they have confirmed bookings.
Indian equity markets saw a positive start on Thursday, September 18, 2025 due to the US Federal Reserve's decision to cut interest rates by 25 basis points. The Sensex and Nifty indices opened with significant gains, with major tech companies like Infosys and HCL tech leading the pack. However, Bajaj Finance and other financial institutions faced some losses in the opening session. With Gift Nifty indicating a positive start and strong investments by Foreign and Domestic Institutional Investors, experts predict better market conditions in the coming days.
After nearly four days of cancelled flights and stranded passengers, Air Canada has reached a tentative agreement with the union representing its cabin crew. The company plans to resume operations gradually on Tuesday evening, but it could take a week for full service to resume. The deal, which still needs to be ratified by union members, includes "transformational change" for workers and the industry. Passengers are advised to only head to the airport if they have confirmed bookings.
The US Federal Reserve announced a 25 basis point cut in interest rates, which was widely expected by economists and investors. The decision was approved by a stronger than expected 11-1 vote, signaling unity within the central bank. The US markets reacted positively to the news, with the Dow Jones and Nasdaq trading higher. The impact of this rate cut on Indian markets is yet to be seen, but Nifty futures suggest a gap-up opening.
As VMS TMT Ltd. prepares to launch its initial public offering, the grey market premium for its mainboard issue is already showing signs of high demand. The company, which manufactures TMT Bars and deals in scrap and binding wires, is set to go public on Wednesday, September 17. With the GMP currently at Rs 23 per share, investors are estimating a potential listing gain of 23.23% per share. The company is offering 1.5 crore shares at a price band of Rs 94 to Rs 99 per share, with a minimum investment of Rs 14,850 for retail investors.
Despite President Trump's dismissal of a top Federal Reserve official, investors shrugged off concerns and pushed stocks higher. The Dow, S&P 500, and Nasdaq all finished the day in positive territory, with the Dow hitting a new record closing high. While the move to remove the official raises questions about the Fed's independence, investors are focused on upcoming economic indicators, including a report on inflation and highly anticipated earnings reports from tech giants like Nvidia. Meanwhile, the digital currency Bitcoin continues to struggle, dropping below $110,000 for the first time in two weeks.
In an effort to reduce reliance on China for key minerals used in advanced technologies, India is exploring partnership with a rebel group in Myanmar to secure rare earth samples. The Ministry of Mines has directed state-owned and private companies to collect samples from Kachin Independence Army-controlled mines and test them in domestic labs. This move comes in light of China's recent export restrictions on rare earth magnets, causing disruptions in global supply chains.
Oracle chairman Larry Ellison, who hails from the Bronx, has surpassed Tesla CEO Elon Musk as the richest person in the world with a net worth of $405 billion. This jump in wealth was reported by Barron's on Wednesday, putting Ellison ahead of Musk's net worth of $390 billion. This milestone marks a shift in the top spot amongst the world's wealthiest individuals.
The US Producer Price Index fell 0.1% in August, bucking expectations of a rise and indicating a potential slowdown in overall economic growth. The decline was driven by a slump in the cost of services, particularly within wholesalers and retailers. The news has led to a drop in Treasury yields and solidifies expectations of an interest rate cut by the Federal Reserve next week.